Literature DB >> 25155446

Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease.

Jeffrey J Horvath1, Stephanie L Austin, Laura E Case, Karla B Greene, Harrison N Jones, Brian J Soher, Priya S Kishnani, Mustafa R Bashir.   

Abstract

INTRODUCTION: Previous examination of whole-body muscle involvement in Pompe disease has been limited to physical examination and/or qualitative magnetic resonance imaging (MRI). In this study we assess the feasibility of quantitative proton-density fat-fraction (PDFF) whole-body MRI in late-onset Pompe disease (LOPD) and compare the results with manual muscle testing.
METHODS: Seven LOPD patients and 11 disease-free controls underwent whole-body PDFF MRI. Quantitative MR muscle group assessments were compared with physical testing of muscle groups.
RESULTS: The 95% upper limits of confidence intervals for muscle groups were 4.9-12.6% in controls and 6.8-76.4% in LOPD patients. LOPD patients showed severe and consistent tongue and axial muscle group involvement, with less marked involvement of peripheral musculature. MRI was more sensitive than physical examination for detection of abnormality in multiple muscle groups.
CONCLUSION: This integrated, quantitative approach to muscle assessment provides more detailed data than physical examination and may have clinical utility for monitoring disease progression and treatment response.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  MRI; Pompe disease; glycogen storage disease; metabolic disease; quantitative MRI

Mesh:

Year:  2015        PMID: 25155446     DOI: 10.1002/mus.24437

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

Review 1.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

2.  Association of paraspinal muscle water-fat MRI-based measurements with isometric strength measurements.

Authors:  Sarah Schlaeger; Stephanie Inhuber; Alexander Rohrmeier; Michael Dieckmeyer; Friedemann Freitag; Elisabeth Klupp; Dominik Weidlich; Georg Feuerriegel; Florian Kreuzpointner; Ansgar Schwirtz; Ernst J Rummeny; Claus Zimmer; Jan S Kirschke; Dimitrios C Karampinos; Thomas Baum
Journal:  Eur Radiol       Date:  2018-07-16       Impact factor: 5.315

3.  Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease.

Authors:  Daniel A Morris; Daniela Blaschke; Alice Krebs; Sima Canaan-Kühl; Ursula Plöckinger; Gesine Knobloch; Thula C Walter; York Kühnle; Leif-Hendrik Boldt; Elisabeth Kraigher-Krainer; Burkert Pieske; Wilhelm Haverkamp
Journal:  Int J Cardiovasc Imaging       Date:  2015-03-06       Impact factor: 2.357

4.  Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease.

Authors:  Adrian G Todd; Jessica A McElroy; Robert W Grange; David D Fuller; Glenn A Walter; Barry J Byrne; Darin J Falk
Journal:  Ann Neurol       Date:  2015-06-30       Impact factor: 10.422

Review 5.  Pompe disease: what are we missing?

Authors:  Benedikt Schoser
Journal:  Ann Transl Med       Date:  2019-07

Review 6.  Physical therapy assessment and whole-body magnetic resonance imaging findings in children with glycogen storage disease type IIIa: A clinical study and review of the literature.

Authors:  Anna Paschall; Aleena A Khan; Syed Faaiz Enam; Tracy Boggs; Ghada Hijazi; Michael Bowling; Stephanie Austin; Laura E Case; Priya Kishnani
Journal:  Mol Genet Metab       Date:  2021-10-09       Impact factor: 4.797

7.  Function, structure and quality of striated muscles in the lower extremities in patients with late onset Pompe Disease-an MRI study.

Authors:  Michael Vaeggemose; Rosa Andersen Mencagli; Julie Schjødtz Hansen; Bianca Dräger; Steffen Ringgaard; John Vissing; Henning Andersen
Journal:  PeerJ       Date:  2021-05-06       Impact factor: 2.984

8.  Muscle imaging data in late-onset Pompe disease reveal a correlation between the pre-existing degree of lipomatous muscle alterations and the efficacy of long-term enzyme replacement therapy.

Authors:  Kai Michael Gruhn; Christoph Malte Heyer; Anne-Katrin Güttsches; Robert Rehmann; Volkmar Nicolas; Tobias Schmidt-Wilcke; Martin Tegenthoff; Matthias Vorgerd; Rudolf Andre Kley
Journal:  Mol Genet Metab Rep       Date:  2015-04-21

9.  Association of Quadriceps Muscle Fat With Isometric Strength Measurements in Healthy Males Using Chemical Shift Encoding-Based Water-Fat Magnetic Resonance Imaging.

Authors:  Thomas Baum; Stephanie Inhuber; Michael Dieckmeyer; Christian Cordes; Stefan Ruschke; Elisabeth Klupp; Pia M Jungmann; Rosanna Farlock; Holger Eggers; Hendrik Kooijman; Ernst J Rummeny; Ansgar Schwirtz; Jan S Kirschke; Dimitrios C Karampinos
Journal:  J Comput Assist Tomogr       Date:  2016 May-Jun       Impact factor: 1.826

10.  Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study.

Authors:  Steven Shinn-Forng Peng; Wuh-Liang Hwu; Ni-Chung Lee; Fuu-Jen Tsai; Wen-Hui Tsai; Yin-Hsiu Chien
Journal:  Orphanet J Rare Dis       Date:  2016-05-17       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.